Researchers developed and validated a risk score to predict febrile neutropenia in cycles 2 to 6 of chemotherapy. The CSR FENCE risk score is a newly created tool that predicts the risk of febrile ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Availity, one of the nation’s leading health information networks, today announced it has acquired Nashville, Tennessee-based RevPoint Healthcare Technologies, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results